BCM
SNTI icon

Bridgeway Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Bridgeway Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,500
Closed -$54.7K – 1338
2024
Q1 		$54.7K Hold
14,500
– – ﹤0.01% 1261
2023
Q4 		$95.7K Hold
14,500
– – ﹤0.01% 1247
2023
Q3 		$61.6K Hold
14,500
– – ﹤0.01% 1284
2023
Q2 		$90.4K Buy
14,500
+5,000
+53% +$48.8K ﹤0.01% 1272
2023
Q1 		$112K Hold
9,500
– – ﹤0.01% 1216
2022
Q4 		$134K Buy
9,500
+7,000
+280% +$171K ﹤0.01% 1172
2022
Q3 		$54K Buy
+2,500
New +$49.3K ﹤0.01% 1345

Other funds holding SNTI

8GI
8VC GP I Austin, Texas $42.8M AUM 15.67% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bridgeway Capital Management's SNTI Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Senti Biosciences Holdings (SNTI) in Q2 2024, closing a stake of 14,500 shares — an estimated $54.7K sold.

Bridgeway Capital Management first reported a position in SNTI in Q3 2022 and held it in 7 quarters. The position peaked at $134K in Q4 2022. 20 funds tracked by Wall St. Rank hold SNTI as of Q2 2024.

  • Bridgeway Capital Management reported no remaining Senti Biosciences Holdings position as of Q2 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 14,500 Senti Biosciences Holdings shares in Q2 2024, an estimated $54.7K.
  • Bridgeway Capital Management first reported a position in Senti Biosciences Holdings in Q3 2022 and held it in 7 quarters.
  • Bridgeway Capital Management's Senti Biosciences Holdings position peaked at $134K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.